Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

WellPoint Drug Safety Monitoring System Expected To Go Live In Mid-2009

Executive Summary

WellPoint is developing a post-marketing drug safety monitoring system that will be capable of drawing data from the 25 million members in its integrated medical and pharmacy insurance plans

You may also be interested in...



Mining The Data: WellPoint Stresses Need For Context In Safety Surveillance

WellPoint is exploring ways to more accurately identify adverse events as it builds a drug safety monitoring system.

Mining The Data: WellPoint Stresses Need For Context In Safety Surveillance

WellPoint is exploring ways to more accurately identify adverse events as it builds a drug safety monitoring system, according to Marcus Wilson, president of the insurer's HealthCore health outcomes subsidiary

Mining The Data: WellPoint Stresses Need For Context In Safety Surveillance

WellPoint is exploring ways to more accurately identify adverse events as it builds a drug safety monitoring system, according to Marcus Wilson, president of the insurer's HealthCore health outcomes subsidiary

Related Content

UsernamePublicRestriction

Register

LL1135415

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel